Cargando…
Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study
Fatigue is one of the most frequent and disabling symptoms of the post-COVID syndrome. In this study, we aimed to assess the effects of transcranial direct current stimulation on fatigue severity in a group of patients with post-COVID syndrome and chronic fatigue. We conducted a double-blind, parall...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116605/ https://www.ncbi.nlm.nih.gov/pubmed/37091591 http://dx.doi.org/10.1093/braincomms/fcad117 |
_version_ | 1785028459965186048 |
---|---|
author | Oliver-Mas, Silvia Delgado-Alonso, Cristina Delgado-Álvarez, Alfonso Díez-Cirarda, María Cuevas, Constanza Fernández-Romero, Lucía Matias-Guiu, Andreu Valles-Salgado, María Gil-Martínez, Lidia Gil-Moreno, María José Yus, Miguel Matias-Guiu, Jorge Matias-Guiu, Jordi A |
author_facet | Oliver-Mas, Silvia Delgado-Alonso, Cristina Delgado-Álvarez, Alfonso Díez-Cirarda, María Cuevas, Constanza Fernández-Romero, Lucía Matias-Guiu, Andreu Valles-Salgado, María Gil-Martínez, Lidia Gil-Moreno, María José Yus, Miguel Matias-Guiu, Jorge Matias-Guiu, Jordi A |
author_sort | Oliver-Mas, Silvia |
collection | PubMed |
description | Fatigue is one of the most frequent and disabling symptoms of the post-COVID syndrome. In this study, we aimed to assess the effects of transcranial direct current stimulation on fatigue severity in a group of patients with post-COVID syndrome and chronic fatigue. We conducted a double-blind, parallel-group, sham-controlled study to evaluate the short-term effects of anodal transcranial direct current stimulation (2 mA, 20 min/day) on the left dorsolateral prefrontal cortex. The modified fatigue impact scale score was used as the primary endpoint. Secondary endpoints included cognition (Stroop test), depressive symptoms (Beck depression inventory) and quality of life (EuroQol-5D). Patients received eight sessions of transcranial direct current stimulation and were evaluated at baseline, immediately after the last session, and one month later. Forty-seven patients were enrolled (23 in the active treatment group and 24 in the sham treatment group); the mean age was 45.66 ± 9.49 years, and 37 (78.72%) were women. The mean progression time since the acute infection was 20.68 ± 6.34 months. Active transcranial direct current stimulation was associated with a statistically significant improvement in physical fatigue at the end of treatment and 1 month as compared with sham stimulation. No significant effect was detected for cognitive fatigue. In terms of secondary outcomes, active transcranial direct current stimulation was associated with an improvement in depressive symptoms at the end of treatment. The treatment had no effects on the quality of life. All the adverse events reported were mild and transient, with no differences between the active stimulation and sham stimulation groups. In conclusion, our results suggest that transcranial direct current stimulation on the dorsolateral prefrontal cortex may improve physical fatigue. Further studies are needed to confirm these findings and optimize stimulation protocols. |
format | Online Article Text |
id | pubmed-10116605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101166052023-04-21 Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study Oliver-Mas, Silvia Delgado-Alonso, Cristina Delgado-Álvarez, Alfonso Díez-Cirarda, María Cuevas, Constanza Fernández-Romero, Lucía Matias-Guiu, Andreu Valles-Salgado, María Gil-Martínez, Lidia Gil-Moreno, María José Yus, Miguel Matias-Guiu, Jorge Matias-Guiu, Jordi A Brain Commun Original Article Fatigue is one of the most frequent and disabling symptoms of the post-COVID syndrome. In this study, we aimed to assess the effects of transcranial direct current stimulation on fatigue severity in a group of patients with post-COVID syndrome and chronic fatigue. We conducted a double-blind, parallel-group, sham-controlled study to evaluate the short-term effects of anodal transcranial direct current stimulation (2 mA, 20 min/day) on the left dorsolateral prefrontal cortex. The modified fatigue impact scale score was used as the primary endpoint. Secondary endpoints included cognition (Stroop test), depressive symptoms (Beck depression inventory) and quality of life (EuroQol-5D). Patients received eight sessions of transcranial direct current stimulation and were evaluated at baseline, immediately after the last session, and one month later. Forty-seven patients were enrolled (23 in the active treatment group and 24 in the sham treatment group); the mean age was 45.66 ± 9.49 years, and 37 (78.72%) were women. The mean progression time since the acute infection was 20.68 ± 6.34 months. Active transcranial direct current stimulation was associated with a statistically significant improvement in physical fatigue at the end of treatment and 1 month as compared with sham stimulation. No significant effect was detected for cognitive fatigue. In terms of secondary outcomes, active transcranial direct current stimulation was associated with an improvement in depressive symptoms at the end of treatment. The treatment had no effects on the quality of life. All the adverse events reported were mild and transient, with no differences between the active stimulation and sham stimulation groups. In conclusion, our results suggest that transcranial direct current stimulation on the dorsolateral prefrontal cortex may improve physical fatigue. Further studies are needed to confirm these findings and optimize stimulation protocols. Oxford University Press 2023-04-10 /pmc/articles/PMC10116605/ /pubmed/37091591 http://dx.doi.org/10.1093/braincomms/fcad117 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Oliver-Mas, Silvia Delgado-Alonso, Cristina Delgado-Álvarez, Alfonso Díez-Cirarda, María Cuevas, Constanza Fernández-Romero, Lucía Matias-Guiu, Andreu Valles-Salgado, María Gil-Martínez, Lidia Gil-Moreno, María José Yus, Miguel Matias-Guiu, Jorge Matias-Guiu, Jordi A Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study |
title | Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study |
title_full | Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study |
title_fullStr | Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study |
title_full_unstemmed | Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study |
title_short | Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study |
title_sort | transcranial direct current stimulation for post-covid fatigue: a randomized, double-blind, controlled pilot study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116605/ https://www.ncbi.nlm.nih.gov/pubmed/37091591 http://dx.doi.org/10.1093/braincomms/fcad117 |
work_keys_str_mv | AT olivermassilvia transcranialdirectcurrentstimulationforpostcovidfatiguearandomizeddoubleblindcontrolledpilotstudy AT delgadoalonsocristina transcranialdirectcurrentstimulationforpostcovidfatiguearandomizeddoubleblindcontrolledpilotstudy AT delgadoalvarezalfonso transcranialdirectcurrentstimulationforpostcovidfatiguearandomizeddoubleblindcontrolledpilotstudy AT diezcirardamaria transcranialdirectcurrentstimulationforpostcovidfatiguearandomizeddoubleblindcontrolledpilotstudy AT cuevasconstanza transcranialdirectcurrentstimulationforpostcovidfatiguearandomizeddoubleblindcontrolledpilotstudy AT fernandezromerolucia transcranialdirectcurrentstimulationforpostcovidfatiguearandomizeddoubleblindcontrolledpilotstudy AT matiasguiuandreu transcranialdirectcurrentstimulationforpostcovidfatiguearandomizeddoubleblindcontrolledpilotstudy AT vallessalgadomaria transcranialdirectcurrentstimulationforpostcovidfatiguearandomizeddoubleblindcontrolledpilotstudy AT gilmartinezlidia transcranialdirectcurrentstimulationforpostcovidfatiguearandomizeddoubleblindcontrolledpilotstudy AT gilmorenomariajose transcranialdirectcurrentstimulationforpostcovidfatiguearandomizeddoubleblindcontrolledpilotstudy AT yusmiguel transcranialdirectcurrentstimulationforpostcovidfatiguearandomizeddoubleblindcontrolledpilotstudy AT matiasguiujorge transcranialdirectcurrentstimulationforpostcovidfatiguearandomizeddoubleblindcontrolledpilotstudy AT matiasguiujordia transcranialdirectcurrentstimulationforpostcovidfatiguearandomizeddoubleblindcontrolledpilotstudy |